Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BioMarin Pharmaceutical Inc
LSE:0HNC
BioMarin Pharmaceutical Inc
LSE:0HNC
Price:
57.48
USD
-2.9%
Market Closed
Market Cap:
$11B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BioMarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
Southern Co
NYSE:SO
|
US |
|
C
|
Credicorp Ltd
SWB:D8V
|
PE |
|
C
|
Caterpillar Inc
XHAM:CAT1
|
US |
|
Koninklijke Ahold Delhaize NV
MIL:1AD
|
NL |
|
C
|
China Southern Airlines Co Ltd
HKEX:1055
|
CN |
|
Neste Oyj
OTC:NTOIY
|
FI |
Wall St Price Targets
0HNC Price Forecast
Based on 28 analysts
Based on 28 analysts
+59% Upside
from
$57.48
today
BioMarin Pharmaceutical Inc (0HNC)’s 12-month stock price forecast through October 2027 has a consensus target of $91.61, implying 59% upside. The forecast is based on price targets from 28 Wall Street analysts.
0HNC Analyst Rating
No ratings yet
No ratings yet
BioMarin Pharmaceutical Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0HNC's stock price target?
Price Target
91.61
USD
91.61
USD
According to Wall Street analysts, the average 1-year price target for 0HNC is 91.61 USD with a low forecast of 60.48 USD and a high forecast of 129.93 USD.
What is the Revenue forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
14%
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
47%
47%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 47%.
What is the Net Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
24%
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.